The global Intravenous Immunoglobulin (IVIG) market size was USD 12.10 Billion in 2022 and is expected to register a revenue CAGR of 7.5% during the forecast period. Increasing prevalence of immunodeficiency disease, rising adoption of Intravenous immunoglobulin treatment and rapid technological advancement in therapy are key factors driving market revenue growth. The report discusses in detail...